Multi-targeted molecular effects of Hibiscus sabdariffa polyphenols: An opportunity for a global approach to obesity

Nutrients

Volumn 9, Issue 8, 2017, Pages

  Herranz López, María ^a   Olivares Vicente, Mariló ^a   Encinar, José Antonio ^a   Barrajón Catalán, Enrique ^a   Segura Carretero, Antonio ^b,c   Joven, Jorge ^d   Micol, Vicente ^a,e  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c Functional Food Research and Development Centre (CIDAF)   (Spain)

^d HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Antioxidants; Dietary supplementation; Epigenetics; Hibiscus sabdariffa; Metabolic stress; Metabolites; Obesity; Polyphenols; Virtual screening

Indexed keywords

ACARBOSE; ADIPONECTIN; ALPHA AMYLASE PANCREAS ISOENZYME; ANTHOCYANIN; ARABINOGALACTAN; CHLOROGENIC ACID; DELPHINIDIN; EPIGALLOCATECHIN; FATTY ACID SYNTHASE; FLAVONOL; FLAVONOL DERIVATIVE; HYDROXYCITRIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOQUERCITRIN; KAEMPFEROL; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; MYRICETIN; NARINGENIN; OLEIC ACID; PECTIN; POLYPHENOL DERIVATIVE; QUERCETIN; REACTIVE OXYGEN METABOLITE; SCUTELLARIN; STAUROSPORINE; STRESS ACTIVATED PROTEIN KINASE; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL; UNINDEXED DRUG; ANTIOXIDANT; PLANT EXTRACT; POLYPHENOL;

BINDING SITE; BIOAVAILABILITY; CHRONIC INFLAMMATION; COMPUTER MODEL; DOWN REGULATION; ENERGY METABOLISM; EPIGENETICS; FATTY ACID OXIDATION; FRACTIONAL INHIBITORY CONCENTRATION INDEX; HIBISCUS SABDARIFFA; HYPERTENSION; IMMUNE RESPONSE; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; LIVER DISEASE; MITOCHONDRIAL RESPIRATION; OBESITY; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; RESPIRATORY CHAIN; REVIEW; TISSUE DISTRIBUTION; WEIGHT REDUCTION; ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; GENETIC EPIGENESIS; HIBISCUS; HUMAN; PHYTOTHERAPY;

ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; HIBISCUS; HUMANS; OBESITY; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; POLYPHENOLS; TISSUE DISTRIBUTION;

EID: 85028087858     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9080907     Document Type: Review

References (120)

1. Luna-Luna, M.; Medina-Urrutia, A.; Vargas-Alarcon, G.; Coss-Rovirosa, F.; Vargas-Barron, J.; Perez-Mendez, O. Adipose tissue in metabolic syndrome: Onset and progression of atherosclerosis. Arch. Med. Res. 2015, 46. [CrossRef] [PubMed]
2. Grundy, S.M. Metabolic syndrome: Connecting and reconciling cardiovascular and diabetes worlds. J. Am. Coll. Cardiol. 2006, 47, 1093–1100. [CrossRef] [PubMed]
3. Okada-Iwabu, M.; Yamauchi, T.; Iwabu, M.; Honma, T.; Hamagami, K.; Matsuda, K.; Yamaguchi, M.; Tanabe, H.; Kimura-Someya, T.; Shirouzu, M.; et al. A small-molecule adipor agonist for type 2 diabetes and short life in obesity. Nature 2013, 503, 493–499. [CrossRef] [PubMed]
4. Rise, M.B.; Pellerud, A.; Rygg, L.Ø.; Steinsbekk, A. Making and maintaining lifestyle changes after participating in group based type 2 diabetes self-management educations: A qualitative study. PLoS ONE 2013, 8, e64009. [CrossRef] [PubMed]
5. Eckel, R.H.; Alberti, K.; Grundy, S.M.; Zimmet, P.Z. The metabolic syndrome. Lancet 2005, 365, 1415–1428. [CrossRef]
6. Ahmadian, M.; Suh, J.M.; Hah, N.; Liddle, C.; Atkins, A.R.; Downes, M.; Evans, R.M. Ppargamma signaling and metabolism: The good, the bad and the future. Nature 2013, 19, 557–566.
7. Leite, C.E.; Mocelin, C.A.; Petersen, G.O.; Leal, M.B.; Thiesen, F.V. Rimonabant: An antagonist drug of the endocannabinoid system for the treatment of obesity. Pharmacol Rep. 2009, 61, 217–224. [CrossRef]
8. Heck, A.M.; Yanovski, J.A.; Calis, K.A. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy 2000, 20, 270–279. [CrossRef] [PubMed]
9. Menendez, J.A.; Joven, J.; Aragones, G.; Barrajon-Catalan, E.; Beltran-Debon, R.; Borras-Linares, I.; Camps, J.; Corominas-Faja, B.; Cufi, S.; Fernandez-Arroyo, S.; et al. Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: A new family of gerosuppressant agents. Cell Cycle 2013, 12, 555–578. [CrossRef] [PubMed]
10. Barrajon-Catalan, E.; Herranz-Lopez, M.; Joven, J.; Segura-Carretero, A.; Alonso-Villaverde, C.; Menendez, J.A.; Micol, V. Molecular promiscuity of plant polyphenols in the management of age-related diseases: Far beyond their antioxidant properties. Adv. Exp. Med. Biol. 2014, 824, 141–159. [PubMed]
11. Beltran-Debon, R.; Rull, A.; Rodriguez-Sanabria, F.; Iswaldi, I.; Herranz-Lopez, M.; Aragones, G.; Camps, J.; Alonso-Villaverde, C.; Menendez, J.A.; Micol, V.; et al. Continuous administration of polyphenols from aqueous rooibos (Aspalathus linearis) extract ameliorates dietary-induced metabolic disturbances in hyperlipidemic mice. Phytomedicine 2011, 18, 414–424. [CrossRef] [PubMed]
12. Herranz-López, M.; Barrajón-Catalán, E.; Segura-Carretero, A.; Menéndez, J.A.; Joven, J.; Micol, V. Lemon verbena (Lippia citriodora) polyphenols alleviate obesity-related disturbances in hypertrophic adipocytes through ampk-dependent mechanisms. Phytomedicine 2015, 22, 605–614. [CrossRef] [PubMed]
13. Ali, F.; Ismail, A.; Kersten, S. Molecular mechanisms underlying the potential antiobesity-related diseases effect of cocoa polyphenols. Mol. Nutr. Food Res. 2014, 58, 33–48. [CrossRef] [PubMed]
14. Amiot, M.J.; Riva, C.; Vinet, A. Effects of dietary polyphenols on metabolic syndrome features in humans: A systematic review. Obes. Rev. 2016, 17, 573–586. [CrossRef] [PubMed]
15. Wang, S.; Moustaid-Moussa, N.; Chen, L.; Mo, H.; Shastri, A.; Su, R.; Bapat, P.; Kwun, I.; Shen, C.L. Novel insights of dietary polyphenols and obesity. J. Nutr. Biochem. 2014, 25, 1–18. [CrossRef] [PubMed]
16. Halliwell, B.; Rafter, J.; Jenner, A. Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: Direct or indirect effects? Antioxidant or not? Am. J. Clin. Nutr. 2005, 81, 268S–276S. [PubMed]
17. Beltran-Debon, R.; Alonso-Villaverde, C.; Aragones, G.; Rodriguez-Medina, I.; Rull, A.; Micol, V.; Segura-Carretero, A.; Fernandez-Gutierrez, A.; Camps, J.; Joven, J. The aqueous extract of hibiscus sabdariffa calices modulates the production of monocyte chemoattractant protein-1 in humans. Phytomedicine 2010, 17, 186–191. [CrossRef] [PubMed]
18. Fernández-Arroyo, S.; Rodríguez-Medina, I.C.; Beltrán-Debón, R.; Pasini, F.; Joven, J.; Micol, V.; Segura-Carretero, A.; Fernández-Gutiérrez, A. Quantification of the polyphenolic fraction and in vitro antioxidant and in vivo anti-hyperlipemic activities of hibiscus sabdariffa aqueous extract. Food Res. Int. 2011, 44, 1490–1495. [CrossRef]
19. Fernandez-Arroyo, S.; Herranz-Lopez, M.; Beltran-Debon, R.; Borras-Linares, I.; Barrajon-Catalan, E.; Joven, J.; Fernandez-Gutierrez, A.; Segura-Carretero, A.; Micol, V. Bioavailability study of a polyphenol-enriched extract from hibiscus sabdariffa in rats and associated antioxidant status. Mol. Nutr. Food Res. 2012, 56, 1590–1595. [CrossRef] [PubMed]
20. Herranz-Lopez, M.; Fernandez-Arroyo, S.; Perez-Sanchez, A.; Barrajon-Catalan, E.; Beltran-Debon, R.; Menendez, J.A.; Alonso-Villaverde, C.; Segura-Carretero, A.; Joven, J.; Micol, V. Synergism of plant-derived polyphenols in adipogenesis: Perspectives and implications. Phytomedicine 2012, 19, 253–261. [CrossRef] [PubMed]
21. Joven, J.; Espinel, E.; Rull, A.; Aragones, G.; Rodriguez-Gallego, E.; Camps, J.; Micol, V.; Herranz-Lopez, M.; Menendez, J.A.; Borras, I.; et al. Plant-derived polyphenols regulate expression of mirna paralogs mir-103/107 and mir-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice. Biochim. Biophys. Acta. 2012, 1820, 894–899. [CrossRef] [PubMed]
22. Joven, J.; March, I.; Espinel, E.; Fernandez-Arroyo, S.; Rodriguez-Gallego, E.; Aragones, G.; Beltran-Debon, R.; Alonso-Villaverde, C.; Rios, L.; Martin-Paredero, V.; et al. Hibiscus sabdariffa extract lowers blood pressure and improves endothelial function. Mol. Nutr. Food Res. 2014, 58, 1374–1378. [CrossRef] [PubMed]
23. Villalpando-Arteaga, E.V.; Mendieta-Condado, E.; Esquivel-Solis, H.; Canales-Aguirre, A.A.; Galvez-Gastelum, F.J.; Mateos-Diaz, J.C.; Rodriguez-Gonzalez, J.A.; Marquez-Aguirre, A.L. Hibiscus sabdariffa l. Aqueous extract attenuates hepatic steatosis through down-regulation of ppar-gamma and srebp-1c in diet-induced obese mice. Food Funct. 2013, 4, 618–626. [CrossRef] [PubMed]
24. Yang, M.Y.; Peng, C.H.; Chan, K.C.; Yang, Y.S.; Huang, C.N.; Wang, C.J. The hypolipidemic effect of hibiscus sabdariffa polyphenols via inhibiting lipogenesis and promoting hepatic lipid clearance. J. Agric. Food Chem. 2010, 58, 850–859. [CrossRef] [PubMed]
25. Howitz, K.T.; Sinclair, D.A. Xenohormesis: Sensing the chemical cues of other species. Cell 2008, 133, 387–391. [CrossRef] [PubMed]
26. Lamming, D.W.; Wood, J.G.; Sinclair, D.A. Small molecules that regulate lifespan: Evidence for xenohormesis. Mol. Microbiol. 2004, 53, 1003–1009. [CrossRef] [PubMed]
27. Falcone Ferreyra, M.L.; Rius, S.P.; Casati, P. Flavonoids: Biosynthesis, biological functions, and biotechnological applications. Front. Plant Sci. 2012, 3, 222. [CrossRef] [PubMed]
28. Cramer, G.R.; Urano, K.; Delrot, S.; Pezzotti, M.; Shinozaki, K. Effects of abiotic stress on plants: A systems biology perspective. BMC Plant Biol. 2011, 11, 163. [CrossRef] [PubMed]
29. Hooper, P.L.; Hooper, P.L.; Tytell, M.; Vígh, L. Xenohormesis: Health benefits from an eon of plant stress response evolution. Cell Stress Chaperones 2010, 15, 761–770. [CrossRef] [PubMed]
30. Pandey, K.B.; Rizvi, S.I. Plant polyphenols as dietary antioxidants in human health and disease. Oxid. Med. Cell. Longev. 2009, 2, 270–278. [CrossRef] [PubMed]
31. Lima, G.; Vianello, F.; Corrêa, C.; Campos, R.; Borguini, M. Polyphenols in fruits and vegetables and its effect on human health. Food Nutr. Sci. 2014, 5, 1065–1082. [CrossRef]
32. Manach, C.; Scalbert, A.; Morand, C.; Rémésy, C.; Jiménez, L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727–747. [PubMed]
33. Scalbert, A.; Williamson, G. Dietary intake and bioavailability of polyphenols. J. Nutr. 2000, 130, 2073s–2085s. [PubMed]
34. Devalaraja, S.; Jain, S.; Yadav, H. Exotic fruits as therapeutic complements for diabetes, obesity and metabolic syndrome. Food Res. Int. 2011, 44, 1856–1865. [CrossRef] [PubMed]
35. Tufts, H.R.; Harris, C.S.; Bukania, Z.N.; Johns, T. Antioxidant and anti-inflammatory activities of kenyan leafy green vegetables, wild fruits, and medicinal plants with potential relevance for kwashiorkor. Evid. Based Complement Alternat. Med. 2015, 2015, 807158. [CrossRef] [PubMed]
36. Brglez Mojzer, E.; Knez Hrncic, M.; Skerget, M.; Knez, Z.; Bren, U. Polyphenols: Extraction methods, antioxidative action, bioavailability and anticarcinogenic effects. Molecules 2016, 21, 901. [CrossRef] [PubMed]
37. Rodriguez-Medina, I.C.; Beltran-Debon, R.; Molina, V.M.; Alonso-Villaverde, C.; Joven, J.; Menendez, J.A.; Segura-Carretero, A.; Fernandez-Gutierrez, A. Direct characterization of aqueous extract of hibiscus sabdariffa using HPLC with diode array detection coupled to ESI and ion trap MS. J. Sep. Sci. 2009, 32, 3441–3448. [CrossRef] [PubMed]
38. Serban, C.; Sahebkar, A.; Ursoniu, S.; Andrica, F.; Banach, M. Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension: A systematic review and meta-analysis of randomized controlled trials. J. Hypertens. 2015, 33, 1119–1127. [CrossRef] [PubMed]
39. Chin, K.L.; Zhen, J.; Qi, Y.; Chin, S.L.; Breithaupt, M.; Wu, Q.L.; Simon, J.; Henson, J.; Ferchaud, V. A comparative evaluation: Phytochemical composition and antioxidant capacity of three roselle (Hibiscus sabdariffa L.) accessions. Acta. Hortic. 2016, 1125, 99–107. [CrossRef]
40. Sindi, H.A.; Marshall, L.J.; Morgan, M.R.A. Comparative chemical and biochemical analysis of extracts of hibiscus sabdariffa. Food Chem. 2014, 164, 23–29. [CrossRef] [PubMed]
41. Villani, T.; Juliani, H.R.; Simon, J.E.; Wu, Q.L. Hibiscus sabdariffa: Phytochemistry, quality control and health properties. ACS Symp. Ser. 2013, 1127, 209–230.
42. Huang, W.Y.; Zhang, H.C.; Liu, W.X.; Li, C.Y. Survey of antioxidant capacity and phenolic composition of blueberry, blackberry, and strawberry in Nanjing. J. Zhejiang Univ. Sci. B 2012, 13, 94–102. [CrossRef] [PubMed]
43. Bowen-Forbes, C.S.; Zhang, Y.; Nair, M.G. Anthocyanin content, antioxidant, anti-inflammatory and anticancer properties of blackberry and raspberry fruits. Food Comp. Anal. 2010, 23, 554–560. [CrossRef]
44. Chang, Y.C.; Huang, K.X.; Huang, A.C.; Ho, Y.C.; Wang, C.J. Hibiscus anthocyanins-rich extract inhibited LDL oxidation and oxLDL-mediated macrophages apoptosis. Food Chem. Toxicol. 2006, 44, 1015–1023. [CrossRef] [PubMed]
45. Tsai, P.J.; McIntosh, J.; Pearce, P.; Camden, B.; Jordan, B.R. Anthocyanin and antioxidant capacity in roselle (Hhibiscus sabdariffa L.) extract. Food Res. Int. 2002, 35, 351–356. [CrossRef]
46. Mahdavi, S.A.; Jafari, S.M.; Ghorbani, M.; Assadpoor, E. Spray-drying microencapsulation of anthocyanins by natural biopolymers: A review. Drying Technol. 2014, 32, 509–518. [CrossRef]
47. Avior, Y.; Bomze, D.; Ramon, O.; Nahmias, Y. Flavonoids as dietary regulators of nuclear receptor activity. Food Funct. 2013, 4, 831–844. [CrossRef] [PubMed]
48. Joven, J.; Micol, V.; Segura-Carretero, A.; Alonso-Villaverde, C.; Menéndez, J.A.; Aragonès, G.; Barrajón-Catalán, E.; Beltrán-Debón, R.; Camps, J.; Cufí, S.; et al. Polyphenols and the modulation of gene expression pathways: Can we eat our way out of the danger of chronic disease? Crit. Rev. Food Sci. Nutr. 2014, 54, 985–1001. [CrossRef] [PubMed]
49. Ezzat, S.M.; Salama, M.M.; Seif El-Din, S.H.; Saleh, S.; El-Lakkany, N.M.; Hammam, O.A.; Salem, M.B.; Botros, S.S. Metabolic profile and hepatoprotective activity of the anthocyanin-rich extract of Hibiscus sabdariffa calyces. Pharm. Biol. 2016, 54, 3172–3181. [CrossRef] [PubMed]
50. Borrás-Linares, I.; Herranz-López, M.; Barrajón-Catalán, E.; Arráez-Román, D.; González-Álvarez, I.; Bermejo, M.; Gutiérrez, A.F.; Micol, V.; Segura-Carretero, A. Permeability study of polyphenols derived from a phenolic-enriched hibiscus sabdariffa extract by UHPLC-ESI-UHR-QQ-TOF-MS. Int. J. Mol. Sci. 2015, 16, 18396–18411. [CrossRef] [PubMed]
51. Muller, B.M.; Franz, G. Chemical structure and biological activity of polysaccharides from Hibiscus sabdariffa. Planta Med. 1992, 58, 60–67. [CrossRef] [PubMed]
52. Sayago-Ayerdi, S.G.; Arranz, S.; Serrano, J.; Goni, I. Dietary fiber content and associated antioxidant compounds in roselle flower (Hibiscus sabdariffa L.) beverage. J. Agric. Food Chem. 2007, 55, 7886–7890. [CrossRef] [PubMed]
53. Beltran-Debon, R.; Rodriguez-Gallego, E.; Fernandez-Arroyo, S.; Senan-Campos, O.; Massucci, F.A.; Hernandez-Aguilera, A.; Sales-Pardo, M.; Guimera, R.; Camps, J.; Menendez, J.A.; et al. The acute impact of polyphenols from hibiscus sabdariffa in metabolic homeostasis: An approach combining metabolomics and gene-expression analyses. Food Funct. 2015, 6, 2957–2966. [CrossRef] [PubMed]
54. Efferth, T.; Koch, E. Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Curr. Drug Targets 2011, 12, 122–132. [CrossRef] [PubMed]
55. Yang, Y.; Zhang, Z.; Li, S.; Ye, X.; Li, X.; He, K. Synergy effects of herb extracts: Pharmacokinetics and pharmacodynamic basis. Fitoterapia 2014, 92, 133–147. [CrossRef] [PubMed]
56. Gertsch, J. Botanical drugs, synergy, and network pharmacology: Forth and back to intelligent mixtures. Planta Med. 2011, 77, 1086–1098. [CrossRef] [PubMed]
57. Keith, C.T.; Borisy, A.A.; Stockwell, B.R. Multicomponent therapeutics for networked systems. Nat. Rev. Drug Discov. 2005, 4, 71–78. [CrossRef] [PubMed]
58. Wagner, H.; Ulrich-Merzenich, G. Synergy research: Approaching a new generation of phytopharmaceuticals. Phytomedicine 2009, 16, 97–110. [CrossRef] [PubMed]
59. Olsen, E.K.; Søderholm, K.L.; Isaksson, J.; Andersen, J.H.; Hansen, E. Metabolomic profiling reveals the n-acyl-taurine geodiataurine in extracts from the marine sponge Geodia macandrewii (Bowerbank). J. Nat. Prod. 2016, 79, 1285–1291. [CrossRef] [PubMed]
60. Frank, T.; Janssen, M.; Netzel, M.; Strass, G.; Kler, A.; Kriesl, E.; Bitsch, I. Pharmacokinetics of anthocyanidin-3-glycosides following consumption of Hibiscus sabdariffa L. Extract. J. Clin. Pharmacol. 2005, 45, 203–210. [CrossRef] [PubMed]
61. Nemeth, K.; Piskula, M.K. Food content, processing, absorption and metabolism of onion flavonoids. Crit. Rev. Food Sci. Nutr. 2007, 47, 397–409. [CrossRef] [PubMed]
62. Del Mar Contreras, M.; Borras-Linares, I.; Herranz-Lopez, M.; Micol, V.; Segura-Carretero, A. Further exploring the absorption and enterocyte metabolism of quercetin forms in the caco-2 model using NANO-LC-TOF-MS. Electrophoresis 2016, 37, 998–1006. [CrossRef] [PubMed]
63. Herranz-López, M.; Borrás-Linares, I.; Olivares-Vicente, M.; Gálvez, J.; Segura-Carretero, A.; Micol, V. Correlation between the cellular metabolism of quercetin and its glucuronide metabolite and oxidative stress in hypertrophied 3t3-l1 adipocytes. Phytomedicine 2017, 25, 25–28. [CrossRef] [PubMed]
64. Bandyopadhyay, P.; Ghosh, A.K.; Ghosh, C. Recent developments on polyphenol-protein interactions: Effects on tea and coffee taste, antioxidant properties and the digestive system. Food Funct. 2012, 3, 592–605. [CrossRef] [PubMed]
65. Hansawasdi, C.; Kawabata, J.; Kasai, T. A-amylase inhibitors from roselle (Hibiscus sabdariffa L.) tea. Biosci. Biotechnol. Biochem. 2000, 64, 1041–1043. [CrossRef] [PubMed]
66. Hansawasdi, C.; Kawabata, J.; Kasai, T. Hibiscus acid as an inhibitor of starch digestion in the caco-2 cell model system. Biosci. Biotechnol. Biochem. 2001, 65, 2087–2089. [CrossRef] [PubMed]
67. Carvajal-Zarrabal, O.; Hayward-Jones, P.M.; Orta-Flores, Z.; Nolasco-Hipolito, C.; Barradas-Dermitz, D.M.; Aguilar-Uscanga, M.G.; Pedroza-Hernandez, M.F.; et al. Effect of hibiscus sabdariffa l. Dried calyx ethanol extract on fat absorption-excretion, and body weight implication in rats. J. Biomed. Biotechnol. 2009, 2009, 5. [CrossRef] [PubMed]
68. Rodina, A.V.; Severin, S.E. The role of adiponectin in the pathogenesis of the metabolic syndrome and approach to therapy. Patol. Fiziol. Eksp. Ter. 2013, 15–26.
69. Encinar, J.A.; Fernandez-Ballester, G.; Galiano-Ibarra, V.; Micol, V. In silico approach for the discovery of new ppargamma modulators among plant-derived polyphenols. Drug Des. Devel. Ther. 2015, 9, 5877–5895. [CrossRef] [PubMed]
70. Galiano, V.; Garcia-Valtanen, P.; Micol, V.; Encinar, J.A. Looking for inhibitors of the dengue virus ns5 rna-dependent rna-polymerase using a molecular docking approach. Drug Des. Devel. Ther. 2016, 10, 3163–3181. [CrossRef] [PubMed]
71. Priscilla, D.H.; Roy, D.; Suresh, A.; Kumar, V.; Thirumurugan, K. Naringenin inhibits alpha-glucosidase activity: A promising strategy for the regulation of postprandial hyperglycemia in high fat diet fed streptozotocin induced diabetic rats. Chem. Biol. Interact. 2014, 210, 77–85. [CrossRef] [PubMed]
72. Murphy, M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417, 1–13. [CrossRef] [PubMed]
73. Ray, P.D.; Huang, B.W.; Tsuji, Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 2012, 24, 981–990. [CrossRef] [PubMed]
74. Skonieczna, M.; Hejmo, T.; Poterala-Hejmo, A.; Cieslar-Pobuda, A.; Buldak, R.J. Nadph oxidases: Insights into selected functions and mechanisms of action in cancer and stem cells. Oxid. Med. Cell. Longev. 2017, 2017, 9420539. [CrossRef] [PubMed]
75. Furukawa, S.; Fujita, T.; Shimabukuro, M.; Iwaki, M.; Yamada, Y.; Nakajima, Y.; Nakayama, O.; Makishima, M.; Matsuda, M.; Shimomura, I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 2004, 114, 1752–1761. [CrossRef] [PubMed]
76. Yeop Han, C.; Kargi, A.Y.; Omer, M.; Chan, C.K.; Wabitsch, M.; O'Brien, K.D.; Wight, T.N.; Chait, A. Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: Dissociation of adipocyte hypertrophy from inflammation. Diabetes 2010, 59, 386–396. [PubMed]
77. Sakurai, T.; Ogasawara, J.; Shirato, K.; Izawa, T.; Oh-Ishi, S.; Ishibashi, Y.; Radak, Z.; Ohno, H.; Kizaki, T. Exercise training attenuates the dysregulated expression of adipokines and oxidative stress in white adipose tissue. Oxid. Med. Cell. Longev. 2017, 2017, 9410954. [CrossRef] [PubMed]
78. Yang, L.; Gou, Y.; Zhao, T.; Zhao, J.; Li, F.; Zhang, B.; Wu, X. Antioxidant capacity of extracts from calyx fruits of roselle (Hibiscus sabdariffa l.). Afr. J. Biotechnol. 2012, 11, 4063–4068.
79. Tseng, T.H.; Kao, E.S.; Chu, C.Y.; Chou, F.P.; Lin Wu, H.W.; Wang, C.J. Protective effects of dried flower extracts of hibiscus sabdariffa l. Against oxidative stress in rat primary hepatocytes. Food Chem. Toxicol. 1997, 35, 1159–1164. [CrossRef]
80. Ajiboye, T.O.; Salawu, N.A.; Yakubu, M.T.; Oladiji, A.T.; Akanji, M.A.; Okogun, J.I. Antioxidant and drug detoxification potentials of hibiscus sabdariffa anthocyanin extract. Drug Chem. Toxicol. 2011, 34, 109–115. [CrossRef] [PubMed]
81. Farombi, E.O.; Fakoya, A. Free radical scavenging and antigenotoxic activities of natural phenolic compounds in dried flowers of Hibiscus sabdariffa l. Mol. Nutr. Food Res. 2005, 49, 1120–1128. [CrossRef] [PubMed]
82. Essa, M.M.; Subramanian, P. Hibiscus sabdariffa affects ammonium chloride-induced hyperammonemic rats. Evid. Based Complement Alternat. Med. 2007, 4, 321–325. [CrossRef] [PubMed]
83. Farombi, E.O.; Ige, O.O. Hypolipidemic and antioxidant effects of ethanolic extract from dried calyx of Hibiscus sabdariffa in alloxan-induced diabetic rats. Fundam. Clin. Pharmacol. 2007, 21, 601–609. [CrossRef] [PubMed]
84. Ekor, M.; Adesanoye, O.A.; Udo, I.E.; Adegoke, O.A.; Raji, J.; Farombi, E.O. Hibiscus sabdariffa ethanolic extract protects against dyslipidemia and oxidative stress induced by chronic cholesterol administration in rabbits. Afr. J. Med. Med. Sci. 2010, 39, 161–170. [PubMed]
85. Adeyemi, D.O.; Ukwenya, V.O.; Obuotor, E.M.; Adewole, S.O. Anti-hepatotoxic activities of hibiscus sabdariffa l. In animal model of streptozotocin diabetes-induced liver damage. BMC Complement Altern. Med. 2014, 14, 277. [CrossRef] [PubMed]
86. Ajiboye, T.O.; Raji, H.O.; Adeleye, A.O.; Adigun, N.S.; Giwa, O.B.; Ojewuyi, O.B.; Oladiji, A.T. Hibiscus sabdariffa calyx palliates insulin resistance, hyperglycemia, dyslipidemia and oxidative rout in fructose-induced metabolic syndrome rats. J. Sci. Food Agric. 2016, 96, 1522–1531. [CrossRef] [PubMed]
87. Zuniga-Munoz, A.; Guarner, V.; Diaz-Cruz, A.; Diaz-Diaz, E.; Beltran-Rodriguez, U.; Perez-Torres, I. Modulation of oxidative stress in fatty liver of rat with metabolic syndrome by Hibiscus sabdariffa. Immunol. Endocr. Metab. Agents Med. Chem 2013, 13, 196–205.
88. Greenberg, A.S.; Obin, M.S. Obesity and the role of adipose tissue in inflammation and metabolism. Am. J. Clin. Nutr. 2006, 83, 461s–465s. [PubMed]
89. Kang, Y.E.; Kim, J.M.; Joung, K.H.; Lee, J.H.; You, B.R.; Choi, M.J.; Ryu, M.J.; Ko, Y.B.; Lee, M.A.; Lee, J.; et al. The roles of adipokines, proinflammatory cytokines, and adipose tissue macrophages in obesity-associated insulin resistance in modest obesity and early metabolic dysfunction. PLoS ONE 2016, 11, e0154003. [CrossRef] [PubMed]
90. O'Neill, S.; O'Driscoll, L. Metabolic syndrome: A closer look at the growing epidemic and its associated pathologies. Obes. Rev. 2015, 16, 1–12. [CrossRef] [PubMed]
91. Cancello, R.; Clement, K. Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. Bjog 2006, 113, 1141–1147. [CrossRef] [PubMed]
92. Marseglia, L.; Manti, S.; D'Angelo, G.; Nicotera, A.; Parisi, E.; Di Rosa, G.; Gitto, E.; Arrigo, T. Oxidative stress in obesity: A critical component in human diseases. Int. J. Mol. Sci. 2014, 16, 378–400. [CrossRef] [PubMed]
93. Kao, E.S.; Hsu, J.D.; Wang, C.J.; Yang, S.H.; Cheng, S.Y.; Lee, H.J. Polyphenols extracted from Hibiscus sabdariffa l. Inhibited lipopolysaccharide-induced inflammation by improving antioxidative conditions and regulating cyclooxygenase-2 expression. Biosci. Biotechnol. Biochem. 2009, 73, 385–390. [CrossRef] [PubMed]
94. Hashimoto, K.; Ichiyama, T.; Hasegawa, M.; Hasegawa, S.; Matsubara, T.; Furukawa, S. Cysteinyl leukotrienes induce monocyte chemoattractant protein-1 in human monocyte/macrophages via mitogen-activated protein kinase and nuclear factor-kappab pathways. Int. Arch. Allergy. Immunol. 2009, 149, 275–282. [CrossRef] [PubMed]
95. Hopkins, A.L.; Lamm, M.G.; Funk, J.L.; Ritenbaugh, C. Hibiscus sabdariffa l. In the treatment of hypertension and hyperlipidemia: A comprehensive review of animal and human studies. Fitoterapia 2013, 85, 84–94. [CrossRef] [PubMed]
96. Herrera-Arellano, A.; Miranda-Sanchez, J.; Avila-Castro, P.; Herrera-Alvarez, S.; Jimenez-Ferrer, J.E.; Zamilpa, A.; Roman-Ramos, R.; Ponce-Monter, H.; Tortoriello, J. Clinical effects produced by a standardized herbal medicinal product of hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial. Planta Med. 2007, 73, 6–12. [CrossRef] [PubMed]
97. Nwachukwu, D.C.; Aneke, E.; Nwachukwu, N.Z.; Obika, L.F.; Nwagha, U.I.; Eze, A.A. Effect of hibiscus sabdariffaon blood pressure and electrolyte profile of mild to moderate hypertensive nigerians: A comparative study with hydrochlorothiazide. Niger. J. Clin. Pract. 2015, 18, 762–770. [CrossRef] [PubMed]
98. Perez-Torres, I.; Ruiz-Ramirez, A.; Banos, G.; El-Hafidi, M. Hibiscus sabdariffa Linnaeus (Malvaceae), curcumin and resveratrol as alternative medicinal agents against metabolic syndrome. Cardiovasc. Hematol. Agents Med. Chem. 2013, 11, 25–37. [CrossRef] [PubMed]
99. Alarcon-Aguilar, F.J.; Zamilpa, A.; Perez-Garcia, M.D.; Almanza-Perez, J.C.; Romero-Nunez, E.; Campos-Sepulveda, E.A.; Vazquez-Carrillo, L.I.; Roman-Ramos, R. Effect of Hibiscus sabdariffa on obesity in msg mice. J. Ethnopharmacol. 2007, 114, 66–71. [CrossRef] [PubMed]
100. Gurrola-Díaz, C.M.; García-López, P.M.; Sánchez-Enríquez, S.; Troyo-Sanromán, R.; Andrade-González, I.; Gómez-Leyva, J.F. Effects of hibiscus sabdariffa extract powder and preventive treatment (diet) on the lipid profiles of patients with metabolic syndrome (mesy). Phytomedicine 2010, 17, 500–505. [CrossRef] [PubMed]
101. Gosain, S.; Ircchiaya, R.; Sharma, P.C.; Thareja, S.; Kalra, A.; Deep, A.; Bhardwaj, T.R. Hypolipidemic effect of ethanolic extract from the leaves of Hibiscus sabdariffa l. In hyperlipidemic rats. Acta. Pol. Pharm. 2010, 67, 179–184. [PubMed]
102. Ochani, P.C.; D'Mello, P. Antioxidant and antihyperlipidemic activity of Hibiscus sabdariffa linn. Leaves and calyces extracts in rats. Indian. J. Exp. Biol. 2009, 47, 276–282. [PubMed]
103. Srivastava, R.A.K.; Pinkosky, S.L.; Filippov, S.; Hanselman, J.C.; Cramer, C.T.; Newton, R.S. Amp-activated protein kinase: An emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases: Thematic review series: New lipid and lipoprotein targets for the treatment of cardiometabolic diseases. J. Lipid. Res. 2012, 53, 2490–2514. [CrossRef] [PubMed]
104. Yamauchi, T.; Kamon, J.; Minokoshi, Y.; Ito, Y.; Waki, H.; Uchida, S.; Yamashita, S.; Noda, M.; Kita, S.; Ueki, K.; et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating amp-activated protein kinase. Nat. Med. 2002, 8, 1288–1295. [CrossRef] [PubMed]
105. Calleri, E.; Pochetti, G.; Dossou, K.S.S.; Laghezza, A.; Montanari, R.; Capelli, D.; Prada, E.; Loiodice, F.; Massolini, G.; Bernier, M.; et al. Resveratrol and its metabolites bind to ppars. Chembiochem 2014, 15, 1154–1160. [CrossRef] [PubMed]
106. Lu, K.; Han, M.; Ting, H.L.; Liu, Z.; Zhang, D. Scutellarin from scutellaria baicalensis suppresses adipogenesis by upregulating pparalpha in 3T3-L1 cells. J. Nat. Prod. 2013, 76, 672–678. [CrossRef] [PubMed]
107. Laghezza, A.; Montanari, R.; Lavecchia, A.; Piemontese, L.; Pochetti, G.; Iacobazzi, V.; Infantino, V.; Capelli, D.; De Bellis, M.; Liantonio, A.; et al. On the metabolically active form of metaglidasen: Improved synthesis and investigation of its peculiar activity on peroxisome proliferator-activated receptors and skeletal muscles. ChemMedChem 2015, 10, 555–565. [CrossRef] [PubMed]
108. Vanden Berghe, W. Epigenetic impact of dietary polyphenols in cancer chemoprevention: Lifelong remodeling of our epigenomes. Pharmacol. Res. 2012, 65, 565–576. [CrossRef] [PubMed]
109. Li, W.; Guo, Y.; Zhang, C.; Wu, R.; Yang, A.Y.; Gaspar, J.; Kong, A.N.T. Dietary phytochemicals and cancer chemoprevention: A perspective on oxidative stress, inflammation, and epigenetics. Chem. Res. Toxicol. 2016, 29, 2071–2095. [CrossRef] [PubMed]
110. Thakur, V.S.; Deb, G.; Babcook, M.A.; Gupta, S. Plant phytochemicals as epigenetic modulators: Role in cancer chemoprevention. AAPS J. 2014, 16, 151–163. [CrossRef] [PubMed]
111. Pan, M.H.; Lai, C.S.; Wu, J.C.; Ho, C.T. Epigenetic and disease targets by polyphenols. Curr. Pharm. Des. 2013, 19, 6156–6185. [CrossRef] [PubMed]
112. Bhat, M.I.; Kapila, R. Dietary metabolites derived from gut microbiota: Critical modulators of epigenetic changes in mammals. Nutr. Rev. 2017, 75, 374–389. [CrossRef] [PubMed]
113. Stilling, R.M.; Dinan, T.G.; Cryan, J.F. Microbial genes, brain & behaviour-epigenetic regulation of the gut-brain axis. Genes Brain Behav. 2014, 13, 69–86. [PubMed]
114. Ruiz, P.A.; Braune, A.; Hölzlwimmer, G.; Quintanilla-Fend, L.; Haller, D. Quercetin inhibits tnf-induced nf-κb transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. J. Nutr. 2007, 137, 1208–1215. [PubMed]
115. Rottiers, V.; Naar, A.M. Micrornas in metabolism and metabolic disorders. Nat. Rev. Mol. Cell Biol. 2012, 13, 239–250. [CrossRef] [PubMed]
116. Guardiola, S.; Mach, N. Therapeutic potential of hibiscus sabdariffa: A review of the scientific evidence. Endocrinol. Nutr. 2014, 63, 274–295. [CrossRef] [PubMed]
117. Hardie, D.G. Amp-activated protein kinase: An energy sensor that regulates all aspects of cell function. Genes Dev. 2011, 25, 1895–1908. [CrossRef] [PubMed]
118. Jimenez-Sanchez, C.; Olivares-Vicente, M.; Rodriguez-Perez, C.; Herranz-Lopez, M.; Lozano-Sanchez, J.; Segura Carretero, A.; Fernandez-Gutierrez, A.; Micol, V. Ampk modulatory activity of olive–tree leaves phenolic compounds: Bioassay-guided isolation on adipocyte model and in silico approach. PLoS ONE 2017. [CrossRef] [PubMed]
119. Hardwicke, M.A.; Rendina, A.R.; Williams, S.P.; Moore, M.L.; Wang, L.; Krueger, J.A.; Plant, R.N.; Totoritis, R.D.; Zhang, G.; Briand, J.; et al. A human fatty acid synthase inhibitor binds beta-ketoacyl reductase in the keto-substrate site. Nat. Chem. Biol. 2014, 10, 774–779. [CrossRef] [PubMed]
120. Piemontese, L. Plant food supplements with antioxidant properties for the treatment of chronic and neurodegenerative diseases: Benefits or risks? J. Diet Suppl. 2017, 14, 478–484. [CrossRef] [PubMed]